CXCR6 Regulates the Recruitment of Pro-inflammatory IL-17A-producing T Cells into Atherosclerotic Aortas
Overview
Affiliations
The adaptive immune response is involved in the development and progression of atherosclerosis and IL-17A(+) cells play a role in this disease. Although elevated number of CD4(+) IL-17A(+) (Th17) and IL-17A(+)TCRγδ(+) T cells are found within murine atherosclerotic aortas and human plaques, the mechanisms governing IL-17A(+) T-cell migration to atherosclerotic lesions are unclear. The chemokine receptor CXCR6 is expressed on several T-cell subsets and plays a pro-atherogenic role in atherosclerosis. Here, we used CXCR6-deficient (Cxcr6 (GFP/GFP) ) apolipoprotein E-deficient (Apoe (-/-) ) mice to investigate the involvement of CXCR6 in the recruitment IL-17A(+) T cells to atherosclerotic aortas. Flow cytometric analyses revealed reductions in Th17 and IL-17A(+)TCRγδ(+) T cells within aged Cxcr6 (GFP/GFP) Apoe (-/-) aortas, in comparison with age-matched Cxcr6 (GFP/+) Apoe (-/-) aortas. Although CXCR6-sufficient IL-17A(+) T cells efficiently migrated toward CXCL16, the migration of CXCR6-deficient IL-17A(+) T cells was abolished in transwell assays. Importantly, the recruitment of Cxcr6 (GFP/GFP) Apoe (-/-) IL-17A(+) T cells into the aortas of Apoe (-/-) recipients was markedly reduced in short-term adoptive transfer experiments. Altogether these results demonstrate an important role of CXCR6 in the regulation of pathological Th17 and IL-17A(+)TCRγδ(+) T-cell recruitment into atherosclerotic lesions.
Stoyell-Conti F, Suresh Kumar M, Zigmond Z, Rojas M, Santos Falcon N, Martinez L Atherosclerosis. 2024; 397:118582.
PMID: 39260002 PMC: 11465391. DOI: 10.1016/j.atherosclerosis.2024.118582.
Targeting immune cell recruitment in atherosclerosis.
Doring Y, van der Vorst E, Weber C Nat Rev Cardiol. 2024; 21(11):824-840.
PMID: 38664575 DOI: 10.1038/s41569-024-01023-z.
ILC2-mediated immune crosstalk in chronic (vascular) inflammation.
Kral M, van der Vorst E, Surnov A, Weber C, Doring Y Front Immunol. 2024; 14:1326440.
PMID: 38179045 PMC: 10765502. DOI: 10.3389/fimmu.2023.1326440.
Uvarova A, Stasevich E, Ustiugova A, Mitkin N, Zheremyan E, Sheetikov S Int J Mol Sci. 2023; 24(18).
PMID: 37762093 PMC: 10530726. DOI: 10.3390/ijms241813790.
Jing J, Guo J, Dai R, Zhu C, Zhang Z Front Pharmacol. 2023; 14:1252907.
PMID: 37719851 PMC: 10504665. DOI: 10.3389/fphar.2023.1252907.